tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Eagle Pharmaceuticals's activity chart (see below) currently has 84 price targets and 61 ratings on display.
Analysts average stock forecasts to be materialized ratio is 82.66% with an average time for these price targets to be met of 164.2 days.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 09-Aug-2023. First documented stock forecast 09-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2018
$17
$15.97 (1550.49%)
3 years 1 months 27 days ago
(09-Aug-2023)
9/14 (64.29%)
$-2.23 (-11.60%)
52
Hold Since 02-Mar-2020
$33
$31.97 (3103.88%)
$37
3 years 6 months 23 days ago
(13-Mar-2023)
5/6 (83.33%)
$7.49 (29.36%)
60
Buy
4 years 6 months 9 days ago
(27-Mar-2022)
1/1 (100%)
$46.76 (113.39%)
395
Buy Since 06-Jan-2016
$52
$50.97 (4948.54%)
$57
5 years 5 months 29 days ago
(07-Apr-2021)
9/13 (69.23%)
$12.37 (31.21%)
174
Hold Since 22-Mar-2019
$41
$39.97 (3880.58%)
$52
7 years 6 months 14 days ago
(22-Mar-2019)
27/28 (96.43%)
$-6.15 (-13.04%)
140
What is EGRX (Eagle Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on EGRX (Eagle Pharmaceuticals)?
Which analyst has the current lower performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most bullish on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most reserved on EGRX (Eagle Pharmaceuticals)?
